Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.730
-0.090-1.15%
Volume:124.28M
Turnover:959.16M
Market Cap:89.04B
PE:19.15
High:7.890
Open:7.820
Low:7.620
Close:7.820
Loading ...

CSPC Pharmaceutical - Jmt202 Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
02 May

Ob Holdings - Letters of Intent Entered Into by Orient Biotech With Units of CSPC Pharmaceutical Group

THOMSON REUTERS
·
02 May

BRIEF-CSPC Pharmaceutical Updates On Clinical Study Of Kn026

Reuters
·
30 Apr

CSPC Pharmaceutical - Pivotal Phase Ii/Iii Clinical Study of Kn026 Met Primary Endpoint of Progression-Free Survival (Pfs) at Interim Analysis

THOMSON REUTERS
·
30 Apr

CSPC Innovation Pharmaceutical Swings to Q1 Loss

MT Newswires Live
·
24 Apr

CSPC Pharmaceutical Gets FDA Nod for Cancer Cachexia Drug Trial

MT Newswires Live
·
23 Apr

CSPC Pharmaceutical Gets China Nod for Diabetes Mellitus Combination Drug Trial

MT Newswires Live
·
23 Apr

BRIEF-CSPC Pharmaceutical Says JMT203 (Anti-Gfral Monoclonal Antibody) Obtains Clinical Trial Approval In U.S.

Reuters
·
22 Apr

BRIEF-CSPC Pharmaceutical's Prusogliptin And Metformin Extended-Release Tablets Obtains Clinical Trial Approval

Reuters
·
22 Apr

CSPC Pharmaceutical - Prusogliptin and Metformin Extended-Release Tablets Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
22 Apr

CSPC Pharmaceutical's Influenza Drug Gets China Nod for Registration

MT Newswires Live
·
15 Apr

CSPC Pharmaceutical - Oseltamivir Phosphate for Suspension Obtains Drug Registration Approval by Nmpa

THOMSON REUTERS
·
15 Apr

BRIEF-CSPC Pharmaceutical Says SYS6041 Obtains Clinical Trial Approval In U.S.

Reuters
·
14 Apr

Executive Chairman of CSPC Pharmaceutical Group Dongchen Cai Buys More Stock

Simply Wall St.
·
12 Apr

BRIEF-CSPC Pharmaceutical Says SYH2046 Tablets Obtains Clinical Trial Approval From NMPA China

Reuters
·
11 Apr

CSPC Pharmaceutical Gets China Nod for Trial Of Cardiac Drug

MT Newswires Live
·
11 Apr

CSPC Pharma Gets US FDA Nod for Anti-Tumor Drug Trials

MT Newswires Live
·
09 Apr

BRIEF-CSPC Pharmaceutical Says Bi-Functional Fusion Protein Drug Obtains Clinical Trial Approval

Reuters
·
08 Apr

CSPC Pharmaceutical - Jmt108 (Bi-Functional Fusion Protein Drug) Obtained Approval From Nmpa to Conduct Clinical Trials in China

THOMSON REUTERS
·
08 Apr

CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Smaller Dividend Than Last Year

Simply Wall St.
·
05 Apr